[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360707-105":59,"doc-detail-360707-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","elemene-enhances-the-efficacy-of-pd-l1-inhibitor-in-lung-cancer-by-reprogramming-tumor-associated-macrophages-to-m1-phenotype-via-suppressing-flt1pi3kakt-signaling","β-elemene enhances the efficacy of PD-L1 inhibitor in lung cancer by reprogramming tumor-associated macrophages to M1 phenotype via suppressing FLT1/PI3K/AKT signaling","","Immune checkpoint inhibitors targeting PD-1/PD-L1 benefit only a limited fraction of lung cancer patients with high PD-L1 expression, while those with low expression generally need combination strategies. This study shows that β-elemene drives M1 polarization of tumor-associated macrophages in C57BL/6 mice and strengthens the antitumor efficacy of an aPD-L1 antibody. RNA sequencing and surface plasmon resonance indicate direct binding of β-elemene to FLT1 and suppression of the PI3K/AKT/FOXO1 pathway, validated with Flt1 knockout models. Co-immunoprecipitation further demonstrates FLT1 intracellular domain binding and phosphorylation of p85α, linking receptor signaling to downstream cascades. Together, these data support clinical evaluation of the combination.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/elemene-enhances-the-efficacy-of-pd-l1-inhibitor-in-lung-cancer-by-reprogramming-tumor-associated-macrophages-to-m1-phenotype-via-suppressing-flt1pi3kakt-signaling/360707/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/elemene-enhances-the-efficacy-of-pd-l1-inhibitor-in-lung-cancer-by-reprogramming-tumor-associated-macrophages-to-m1-phenotype-via-suppressing-flt1pi3kakt-signaling/360707.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does β-elemene improve the effect of PD-L1 blockade in lung cancer models?","Question",{"text":112,"@type":113},"β-elemene promotes M1 polarization of tumor-associated macrophages and enhances the efficacy of the PD-L1 antibody (aPD-L1) in C57BL/6 mice.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What molecular pathway is inhibited by β-elemene?",{"text":117,"@type":113},"β-elemene directly binds FLT1 and suppresses the PI3K/AKT/FOXO1 signaling pathway, which mediates TAM M1 polarization.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is FLT1 important in the synergy between β-elemene and aPD-L1?",{"text":121,"@type":113},"Flt1 knockout models validate the critical role of Flt1 in TAM polarization, and M1 polarization synergizes with aPD-L1 treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360707,1790539206,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Cancer Immunology, Immunotherapy (2026) 75:177  \n[https://doi.org/10.1007/s00262-026-04386-z](https://doi.org/10.1007/s00262-026-04386-z)  \nβ‑elemene enhances the efficacy of PD‑L1 inhibitor in lung cancer by reprogramming tumor‑associated macrophages to M1 phenotype via suppressing FLT1/PI3K/AKT signaling  \nJianmin Wang1 · Yongxin Yu2 · Fenglin Lin3 · Hang Wang4,5 · Weiqi Nian1,6  \nReceived: 28 January 2026 / Accepted: 26 March 2026 © The Author(s) 2026  \nAbstract  \nImmune checkpoint inhibitors (ICI), epitomized by PD-1/PD-L1 antibodies, have ushered in a new era in lung cancer treatment. However, ICI monotherapy is only applicable to a small subset of patients with high PD-L1 expression, while most patients with low expression require combination therapies. In this study, we found that β-elemene promotes M1 polarization of tumor-associated macrophages (TAMs) and enhances the efficacy of PD-L1 antibody (aPD-L1) in C57BL/6 mice. RNA sequencing and surface plasmon resonance revealed that β-elemene directly binds to FLT1 and inhibits the PI3K/AKT/ FOXO1 signaling pathway, thereby mediating TAMs M1 polarization. Using Flt1 knockout mice, we further validated the critical role ofFlt1 in TAMs polarization and confirmed that M1 polarization synergizes with aPD-L1 treatment. Furthermore, co-immunoprecipitation showed that the FLT1 intracellular domain binds to and phosphorylates the p85α subunit, triggering downstream signaling cascades. These findings elucidate the synergistic mechanism between β-elemene and aPD-L1 . Moreover, given the clinical availability of both agents, they provide a strong rationale for further clinical evaluation of this combination therapy.  \nKeywords β-elemene · PD-L1 inhibitor · tumor-associated macrophages · FLT1 · PI3K/AKT pathway  \nJianmin Wang and Yongxin Yu have contributed equally to this work.  \n* Hang Wang [wanghang_114220@163.com](wanghang_114220@163.com)  \n* Weiqi Nian[wnian@itm-oncolab.cn](wnian@itm-oncolab.cn)  \n1 Department of Oncology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China  \n2 Department of Plastic, Aesthetic, Reparative and Reconstructive Surgery/Wound Repair Center, West China Second University Hospital, Sichuan University, Sichuan, China  \n3 Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China  \n4 Department of Endocrinology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China  \n5 College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, China  \n6 Chongqing Municipal Health Commission Key Laboratory for Translational Research in Integrated Chinese and Western Medicine Oncology Diagnosis and Treatment, Chongqing, China  \nIntroduction  \nAs lung cancer remains the leading cause of morbidity and mortality among all malignant tumors [1], developing effective treatments is crucial for improving patient prognosis. Immune checkpoint inhibitors (ICI)—particularly PD-1/ PD-L1 antibodies—have transformed lung cancer therapy. The KEYNOTE-024 [2] and IMpower110 [3] demonstrate that PD-1/PD-L1 antibodies significantly improve progression-free survival (PFS) and overall survival (OS) in nonsmall-cell lung cancer (NSCLC) patients with high PD-L1 expression. However, only a minority of patients have high PD-L1 expression. For the majority of patients with low PD-L1 expression, combination therapies involving PD-1/ PD-L1 antibodies are necessary.  \nThe tumor microenvironment (TME) is a complex system comprising immune cells, blood and lymphatic vessels, and stromal cells, within which tumor cells grow and interact with their surroundings. Hypoxia and immunosuppression are two features of TME that impair therapy response and promote progression. Vascular normalization alleviates hypoxia and enhances immune effector cell  \ninfiltration, shifting the TME from immunosuppressive to immune-active [4] . Conversely, certain tumor-infiltrating myeloid cells drive both angiogenesis and immunosuppression—indicating r","cbCaigmnNt803bh8","https://ap.wps.com/l/cbCaigmnNt803bh8","pdf",3890780,15,"English","# Introduction\n# Materials and methods\n## Mice","[{\"question\":\"How does β-elemene improve the effect of PD-L1 blockade in lung cancer models?\",\"answer\":\"β-elemene promotes M1 polarization of tumor-associated macrophages and enhances the efficacy of the PD-L1 antibody (aPD-L1) in C57BL/6 mice.\"},{\"question\":\"What molecular pathway is inhibited by β-elemene?\",\"answer\":\"β-elemene directly binds FLT1 and suppresses the PI3K/AKT/FOXO1 signaling pathway, which mediates TAM M1 polarization.\"},{\"question\":\"Why is FLT1 important in the synergy between β-elemene and aPD-L1?\",\"answer\":\"Flt1 knockout models validate the critical role of Flt1 in TAM polarization, and M1 polarization synergizes with aPD-L1 treatment.\"}]","β-elemene enhances the efficacy of PD-L1 inhibitor in lung cancer by reprogramming tumor-associated macrophages to M1 phenotype via suppressing FLT1/PI3K/AKT signaling | PDF",1790141275,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1955feeb3d964267aa337990e3a694c6.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/979fef2fd241acd61a51db069e46249e.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52eef7f0333bca023069f0dfc6488efb.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/510a32d9243fcd64b287236e9b33edd1.webp",980,1301]